Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol PulmoSphere versus lactose-blend powder crossover study in adults with persistent asthma
2011-001825-25Phase 2Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of indacaterol in asthma (3 arms), sponsored by Novartis. Primary endpoint: Trough FEV1 after 7 days of treatment. Started Aug 2011; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-001825-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001825-25.